SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001079973-08-000372
Filing Date
2008-04-01
Accepted
2008-04-01 16:38:22
Documents
3
Period of Report
2008-03-27
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K appy_8k-040108.htm 8-K 14115
2 EXHIBIT 3.1 appy_8k-ex3x1.htm EX-3.1 1365
3 EXHIBIT 99.1 appy_8k-ex99x1.htm EX-99.1 5898
  Complete submission text file 0001079973-08-000372.txt   23137
Mailing Address 1585 S. PERRY STREET CASTLE ROCK CO 80104
Business Address 1585 S. PERRY STREET CASTLE ROCK CO 80104 (303) 794-2000
AspenBio Pharma, Inc. (Filer) CIK: 0001167419 (see all company filings)

IRS No.: 841553387 | State of Incorp.: CO | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33675 | Film No.: 08729859
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
Assistant Director 1